Benzidine: a bladder carcinogen.
D000328:Adult; D001713:Biphenyl Compounds / Q000009:adverse effects*; D002273:Carcinogens; D002295:Carcinoma, Transitional Cell / Q000139:chemically induced* / Q000453:epidemiology / Q000628:therapy; D002617:Chemical Industry; D004781:Environmental Exposure; D005500:Follow-Up Studies; D006801:Humans; D007680:Kidney Neoplasms / Q000139:chemically induced / Q000628:therapy; D007682:Kidney Pelvis; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced; D009784:Occupational Diseases / Q000139:chemically induced* / Q000453:epidemiology / Q000628:therapy; D009820:Ohio; D013997:Time Factors; D014052:Toluidines / Q000009:adverse effects; D001743:Urinary Bladder / Q000187:drug effects*; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced* / Q000453:epidemiology / Q000628:therapy
D001713:Biphenyl Compounds; D002273:Carcinogens; D014052:Toluidines